Primary hyperhidrosis, an idiopathic disease that commonly affects the palms, soles, axillae, or craniofacial region, is characterized by perspiration in excess of what is required for physiologic cooling. This disease begins in childhood or adolescence and negatively impacts emotional, physical, and psychologic well‐being. This review explores current therapeutic options for primary hyperhidrosis in the pediatric population, including topical therapies, oral therapies, non‐surgical and procedural interventions, and adjunctive therapies. In addition, this review identifies new and emerging treatments and highlights the need for further research and therapeutic options for this impactful disease.
Remington, C, Ruth, J, Hebert, AA. Primary hyperhidrosis in children: A review of therapeutics. Pediatr Dermatol. 2021; 00: 1– 7. https://doi.org/10.1111/pde.14551
Available for download on Friday, March 04, 2022